OraSure Technologies vs Neuronetics
Neuronetics reported revenue of $149 million in fiscal 2025, 1.3 times OraSure Technologies' $115 million in fiscal 2025. OraSure Technologies' revenue fell 38.1% in its latest year, and Neuronetics' grew 99.2%. OraSure Technologies had an operating margin of -62.6%, against -21.1% at Neuronetics. Free cash flow was −$53 million at OraSure Technologies and −$21 million at Neuronetics.
Side by side
| OraSure Technologies | Neuronetics | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $115M | $149M |
| Revenue growth | −38.1% | 99.2% |
| Revenue growth a year, last 5 years | −7.7% | 24.8% |
| Gross margin | 41.9% | 48.5% |
| Operating margin | −62.6% | −21.1% |
| Net margin | −59.8% | −26.1% |
| Free cash flow | −$53M | −$21M |
| Free cash flow margin | −46.3% | −14.2% |
| Return on capital | — | −37.5% |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $15M | $0M |
| Change in diluted share count | −1.3% | 107.8% |
| Last close | $3.61 | $1.24 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | bought $456,495, sold $0 | bought $4.8 million, sold $270,405 |
| Piotroski F-score | — | 4 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
OraSure TechnologiesNeuronetics
Operating margin
Percent of revenue
OraSure TechnologiesNeuronetics
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
OraSure TechnologiesNeuronetics
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the OraSure Technologies and Neuronetics pages.